title: Varicella zoster virus triggers the immunopathology of giant cell arteritis.
abstract: OBJECTIVE
  Giant cell arteritis (GCA) is a severe form of vasculitis in the elderly. The recent discovery of varicella zoster virus (VZV) in the temporal arteries and adjacent skeletal muscle of patients with GCA, and the rationale and strategy for antiviral and corticosteroid treatment for GCA are reviewed.
  
  
  RESULTS
  The clinical features of GCA include excruciating headache/head pain, often with scalp tenderness, a nodular temporal arteries and decreased temporal artery pulsations. Jaw claudication, night sweats, fever, malaise, and a history of polymyalgia rheumatica (aching and stiffness of large muscles primarily in the shoulder girdle, upper back, and pelvis without objective signs of weakness) are common. ESR and CRP are usually elevated. Diagnosis is confirmed by temporal artery biopsy which reveals vessel wall damage and inflammation, with multinucleated giant cells and/or epithelioid macrophages. Skip lesions are common. Importantly, temporal artery biopsies are pathologically negative in many clinically suspect cases. This review highlights recent virological findings in temporal arteries from patients with pathologically verified GCA and in temporal arteries from patients who manifest clinical and laboratory features of GCA, but whose temporal artery biopsies (Bx) are pathologically negative for GCA (Bx-negative GCA). Virological analysis revealed that VZV is present in most GCA-positive and GCA-negative temporal artery biopsies, mostly in skip areas that correlate with adjacent GCA pathology.
  
  
  CONCLUSIONS
  The presence of VZV in Bx-positive and Bx-negative GCA temporal arteries indicates that VZV triggers the immunopathology of GCA. However, the presence of VZV in about 20% of temporal artery biopsies from non-GCA postmortem controls also suggests that VZV alone is not sufficient to produce disease. Treatment trials should be performed to determine if antiviral agents confer additional benefits to corticosteroids in both Bx-positive and Bx-negative GCA patients. These studies should also examine whether oral antiviral agents and corticosteroids are as effective as intravenous acyclovir and corticosteroids. Appropriate dosage and duration of treatment also remain to be determined.
authors.affiliation: aDepartment of NeurologybDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Don
authors.initials: D
authors.lastname: Gilden
authors.forename: Maria A
authors.initials: MA
authors.lastname: Nagel
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001025:Aortitis / Q000821:virology; D001706:Biopsy; D013700:Giant Cell Arteritis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000821:virology*; D006562:Herpes Zoster / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014645:Herpesvirus 3, Human / Q000302:isolation & purification*; D006801:Humans; D013699:Temporal Arteries / Q000473:pathology / Q000821:virology
chemical_list: D000998:Antiviral Agents